Avior Wealth Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Avior Wealth Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$11	–	3910
2024 Q1	$11	Buy	+7	New	+$10	﹤0.01%	3772

Avior Wealth Management's NGM Position: Q2 2024 in Review

Avior Wealth Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 7 shares — an estimated $11 sold.

Avior Wealth Management first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $11 in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Avior Wealth Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Avior Wealth Management sold 7 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $11.
Avior Wealth Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Avior Wealth Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $11 in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.